
Read More
One of India's Largest Pharmaceutical Companies Receives EMA Approval to Ex...
The European Medicines Agency has approved Lupin's NaMuscla for paediatric patients with non-dystrop...

The European Medicines Agency has approved Lupin's NaMuscla for paediatric patients with non-dystrop...

Lupin Limited has received tentative approval from the US FDA for its Enzalutamide Tablets in 40 mg,...

Companies including Vedanta, Lupin, NMDC, Waaree Energies and Indian Metals reported double-digit re...

Lupin said completion of its proposed acquisition of minority shareholding in Multicare Pharmaceutic...

Lupin received approval from China’s National Medical Products Administration for Oseltamivir Phosph...

Over the past year, the stock has delivered a return of 27.39 per cent, while the three-year return ...

The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales...

Watch out for these stocks in Wednesday’s trading session!...

This pharma company stock went 8 per cent high, do you own it? ...

NSE Nifty 50 index plunged 0.25 per cent to close below 18,200 level while Sensex slipped 150 points...